Content Detail

• Content META

  Title	Arteris Announces Financial Results for the Third Quarter and Estimated Fourth Quarter and Updated Full Year 2025 Guidance
  ID	20499945
  External ID	210600414
  Author
  Published Date	Nov. 4, 2025, 3:06 p.m.
  Summary	This is a paid press release. Contact the press release distributor directly with any inquiries. Arteris Announces Financial Results for the Third Quarter and Estimated Fourth Quarter and Updated Full
  Tags
  URL	https://finance.yahoo.com/news/arteris-announces-financial-results-third-210600414.html
  Sentiment	Negative: 0.02974    Neutral: 0.94699    Positive: 0.02327
  Relevance	0.03448

• Content Details

  Content ID	28294017
  Key	8ef0d7ba-46d9-4ce5-8d15-b49671ab0507
  Content	This is a paid press release. Contact the press release distributor directly with any inquiries. Arteris Announces Financial Results for the Third Quarter and Estimated Fourth Quarter and Updated Full Year 2025 Guidance Arteris, Inc. Tue, November 4, 2025 at 4:06 PM EST 18 min read AIP Arteris, Inc. CAMPBELL, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the third quarter ended September 30, 2025 and provided estimated fourth quarter and updated full year 2025 guidance. “In the third quarter of 2025, we achieved another record with Annual Contract Value plus royalties of $74.9 million, up 24% year-over-year. In addition, we exited the quarter with $104.7 million in Remaining Performance Obligations, up 34% year-over-year and exceeding $100.0 million for the first time in our history,” said K. Charles Janac, President and CEO of Arteris. “Looking ahead, we remain confident in Arteris’ long-term growth opportunity, driven by our growing product portfolio, expanding partnerships and increasing customer demand across high-growth markets such as AI, autonomous driving, and advanced communications. As AI adoption accelerates and system complexity grows with the rise of chiplet-based, multi-die SoC architectures, we believe Arteris’ deep expertise and proven technology uniquely position us to capture these transformative opportunities,” concluded Janac. Third Quarter 2025 Financial Highlights: Revenue of $17.4 million, up 18% year-over-year Annual Contract Value (ACV) plus royalties of $74.9 million, up 24% year-over-year Remaining performance obligation (RPO) of $104.7 million, up 34% year-over-year Operating loss of $8.7 million, compared to an operating loss of $7.9 million in the third quarter of 2024 Non-GAAP operating loss of $3.5 million, compared to a Non-GAAP operating loss of $3.3 million in the third quarter of 2024 Net loss of $9.0 million or $0.21 per share Non-GAAP net loss of $3.8 million or $0.09 per share Non-GAAP free cash flow of positive $2.5 million or 14% of revenue Third Quarter 2025 Business Highlights: Altera expanded its use and licenses of Arteris existing IP products and licensed Magillem integration automation software products, as well as FlexGen Smart NoC IP for its end-to-end programmable solutions; AMD ordered additional licenses of Arteris technology in the third quarter, following its multi-project license of FlexGen in the second quarter; Added automotive and industrial FlexGen customers, with Dream Chip and a leading automotive OEM taking licenses, and NanoXplore using FlexGen Smart NoC IP for its aerospace SoC designs; 2V Systems licensed Ncore and FlexNoC interconnect for development of a high bandwidth, low latency IO Hub chiplet; Expanded our collaboration with the Alibaba Damo Academy, with the goal of better integration and optimized performance for their CPU cores and our mutual customers; and Joined the Ultra Accelerator Link Consortium (UALink), serving a key role in AI data movement in chiplets and SoCs. Story Continues Non-GAAP gross profit, Non-GAAP gross margin, Non-GAAP operating loss, Non-GAAP net loss, Non-GAAP net loss per share, and free cash flow are Non-GAAP financial measures. Additional information on Arteris’ historic reported results, including a reconciliation of these Non-GAAP financial measures to their most comparable GAAP measures, is included in the financial tables below. Estimated Fourth Quarter and Updated Full Year 2025 Guidance: Q4 2025 FY 2025 (in millions) ACV + royalties $74.0 - $78.0 $74.0 - $78.0 Revenue $18.4 - $18.8 $68.8 - $69.2 Non-GAAP operating loss $2.3 - $3.3 $12.5 - $13.5 Free cash flow $0.2 - $3.2 $2.5 - $5.5 The guidance provided above are forward-looking statements and reflects Arteris' expectations as of today's date. Actual results may differ materially. Refer to the section titled "Forward-Looking Statements" below for information on the factors, among others, that could cause our actual results to differ materially from these forward-looking statements. A reconciliation of Non-GAAP guidance measures reported above to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of expenses that may be incurred in the future, although it is important to note that these factors could be material to Arteris' results computed in accordance with GAAP. Definitions of the other business metrics used in this press release including ACV, confirmed design starts and RPO are included below under the heading “Other Business Metrics.” Conference Call Arteris will host a conference call on November 4, 2025 to review its third quarter 2025 financial results and to discuss its financial outlook. Time: 4:30PM ET United States/Canada Toll Free: 1-800-717-1738 International Toll: 1-646-307-1865 A live webcast will also be available in the Investor Relations section of Arteris’ website at: https://ir.arteris.com/events-and-presentations A replay of the webcast will be available in the Investor Relations section of Arteris' website approximately two hours after the conclusion of the call and remain available for approximately 30 calendar days. About Arteris Arteris is a global leader in system IP used in semiconductors to accelerate the creation of high-performance, power-efficient silicon. Arteris network-on-chip (NoC) interconnect IP and system-on-chip (SoC) integration automation software are used by the world's top semiconductor and technology companies to improve overall performance, engineering productivity, reduce risk, lower costs, and bring complex designs to market faster. Learn more at arteris.com. © 2004-2025 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners. Investor Contacts: Arteris Nick Hawkins Chief Financial Officer IR@arteris.com Sapphire Investor Relations, LLC Erica Mannion and Michael Funari +1 617 542 6180 IR@arteris.com Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including but not limited to, statements regarding our long-term growth opportunity and future financial and operating performance, including our GAAP and Non-GAAP estimated fourth quarter and updated full year 2025 guidance. The words such as "may," "will," "could," "expect," "approximately," "believe," "estimate," "future," "guidance," "outlook," and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements contained herein are based on our historical performance and our current plans, estimates and expectations and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent our expectations as of the date of this press release. Subsequent events may cause these expectations to change, and we disclaim any obligation to update the forward-looking statements in the future, except as required by law. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from our current expectations. Important factors that could cause actual results to differ materially from those anticipated in our forward-looking statements include, but are not limited to, the significant competition we face from larger companies and third-party providers; our history of net losses; whether semiconductor companies in the automotive market, enterprise computing market, communications market, consumer electronics market, and industrial markets incorporate our solutions into their end products and the growth and economic stability of these end markets; our ability to attract new customers and the extent to which our customers renew their subscriptions for our solutions; the ability of our customers’ end products achieving market acceptance or growth; our ability to sustain or grow our licensing revenue; our ability, and the cost, to successfully execute on research and development efforts; the occurrence of product errors or defects in our solutions; if we fail to offer high-quality support; the occurrence of macro-economic conditions that adversely impact us, our customers and their end product markets including, but not limited to, the imposition of tariffs in markets where we operate; the effects of geopolitical conflicts, such as the military conflict between Russia and Ukraine as well as the ongoing conflict in the Middle East; the range of regulatory, operational, financial and political risks we are exposed to as a result of our dependence on international customers and operations; our ability to protect our proprietary technology and inventions through patents and other IP rights; whether we are subject to any liabilities or fines as a result of government regulation, including import, export and economic sanctions laws and regulations; the occurrence of a disruption in our networks or a security breach; risks associated with doing business in China, including as a result of changes to trade relations between the United States and China; and the other factors described under the heading “Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 to be filed with the Securities and Exchange Commission (SEC) on November 4, 2025. All forward-looking statements reflect our beliefs and assumptions only as of the date of this press release. We undertake no obligation to update forward-looking statements to reflect future events or circumstances. Our results for the quarter ended September 30, 2025 are not necessarily indicative of our operating results for any future periods. Arteris, Inc. Condensed Consolidated Statements of Operations (In thousands, except share and per share data) (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Revenue Licensing, support and maintenance $ 15,896 $ 13,507 $ 46,319 $ 38,799 Variable royalties and other 1,512 1,206 4,123 3,436 Total revenue 17,408 14,713 50,442 42,235 Cost of revenue 1,766 1,461 5,034 4,387 Gross profit 15,642 13,252 45,408 37,848 Operating expenses: Research and development 12,648 11,923 36,681 33,475 Sales and marketing 6,850 4,962 19,714 15,431 General and administrative 4,858 4,286 13,683 13,436 Total operating expenses 24,356 21,171 70,078 62,342 Loss from operations (8,714 ) (7,919 ) (24,670 ) (24,494 ) Interest expense (49 ) (55 ) (139 ) (199 ) Other income (expense), net 636 775 2,140 2,576 Loss before income taxes and loss from equity method investment (8,127 ) (7,199 ) (22,669 ) (22,117 ) Loss from equity method investment, net of tax 484 580 2,079 2,064 Provision for (benefit from) income taxes 380 (92 ) 1,494 1,253 Net loss $ (8,991 ) $ (7,687 ) $ (26,242 ) $ (25,434 ) Net loss per share attributable to common stockholders, basic $ (0.21 ) $ (0.20 ) $ (0.63 ) $ (0.66 ) Weighted-average shares used in computing per share amounts, basic and diluted 42,743,518 39,295,743 41,812,256 38,496,838 Arteris, Inc. Condensed Consolidated Balance Sheets (In thousands, except share and per share data) As of September 30, December 31, 2025 2024 ASSETS Current assets: Cash and cash equivalents $ 17,417 $ 13,684 Short-term investments 21,567 30,157 Accounts receivable, net of allowance of $123 and $131 as of September 30, 2025 and December 31, 2024, respectively 16,480 20,608 Prepaid expenses and other current assets 5,566 4,634 Total current assets 61,030 69,083 Property and equipment, net 4,461 4,019 Long-term investments 17,237 8,504 Equity method investment 3,723 5,802 Operating lease right-of-use assets 4,195 3,838 Intangibles, net 2,361 3,024 Goodwill 4,178 4,178 Other assets 10,552 7,687 TOTAL ASSETS $ 107,737 $ 106,135 LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities: Accounts payable $ 517 $ 539 Accrued expenses and other current liabilities 17,212 15,899 Operating lease liabilities, current 1,186 917 Deferred revenue, current 46,243 40,445 Vendor financing arrangements, current 1,614 1,482 Total current liabilities 66,772 59,282 Deferred revenue, noncurrent 39,629 35,177 Operating lease liabilities, noncurrent 3,431 2,998 Vendor financing arrangements, noncurrent 624 594 Deferred income, noncurrent 6,749 7,631 Other liabilities 1,981 1,641 Total liabilities 119,186 107,323 Stockholders' deficit: Preferred stock, par value of $0.001 - 10,000,000 shares authorized and no shares issued and outstanding as of both September 30, 2025 and December 31, 2024 — — Common stock, par value of $0.001 - 300,000,000 shares authorized as of both September 30, 2025 and December 31, 2024; 43,584,272 and 40,724,936 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 43 40 Additional paid-in capital 151,377 135,522 Accumulated other comprehensive income 258 135 Accumulated deficit (163,127 ) (136,885 ) Total stockholders' deficit (11,449 ) (1,188 ) TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 107,737 $ 106,135 Arteris, Inc. Condensed Consolidated Statements of Cash Flows (In thousands) Nine Months Ended September 30, 2025 2024 CASH FLOWS FROM OPERATING ACTIVITIES: Net loss $ (26,242 ) $ (25,434 ) Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation and amortization 2,532 2,474 Stock-based compensation 13,765 11,807 Amortization of deferred income (882 ) (885 ) Loss from equity method investment 2,079 2,064 Net accretion of discounts on available-for-sale securities (306 ) (522 ) Other, net 390 124 Changes in operating assets and liabilities: Accounts receivable, net 4,128 3,288 Prepaid expenses and other assets (3,740 ) (1,249 ) Accounts payable (77 ) (43 ) Accrued expenses and other liabilities 1,666 1,494 Deferred revenue 10,250 8,793 Net cash provided by operating activities 3,563 1,911 CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment (1,254 ) (274 ) Purchases of available-for-sale securities (25,308 ) (25,997 ) Proceeds from maturities of available-for-sale securities and other 25,515 29,169 Net cash (used in) provided by investing activities (1,047 ) 2,898 CASH FLOWS FROM FINANCING ACTIVITIES: Principal payments under vendor financing arrangements (882 ) (1,438 ) Proceeds from exercise of stock options 1,523 703 Proceeds from employee stock purchase plan 535 — Other financing activities 99 59 Net cash provided by (used in) financing activities 1,275 (676 ) NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 3,791 4,133 CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period 14,072 14,084 CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period $ 17,863 $ 18,217 Non-GAAP Financial Measures To supplement our financial results, which are prepared and presented in accordance with GAAP, we use certain non-GAAP financial measures, as described below, to understand and evaluate our core performance. These non-GAAP measures, which may be different than similarly-titled measures used by other companies, are presented to enhance investors’ overall understanding of our financial performance and should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We define "Non-GAAP gross profit" and "Non-GAAP gross margin" as GAAP gross profit and GAAP gross margin, respectively, adjusted for stock-based compensation expense included in cost of revenue and amortization of acquired intangible assets included in cost of revenue. We define “Non-GAAP loss from operations” as our GAAP loss from operations adjusted to exclude stock-based compensation expense and amortization of acquired intangible assets. We define “Non-GAAP net loss” as our net loss adjusted to exclude stock-based compensation and amortization of acquired intangible assets. We define “Non-GAAP net loss per share attributable to common stockholders, basic and diluted”, as our Non-GAAP net loss divided by our GAAP weighted-average number of shares outstanding for the period on a basic or diluted basis, respectively. Management uses this non-GAAP measure to evaluate the performance of our business on a comparable basis from period to period. The above items are excluded from our Non-GAAP gross profit, Non-GAAP loss from operations and Non-GAAP net loss because these items are non-cash in nature, or are not indicative of our core operating performance, and render comparisons with prior periods and competitors less meaningful. We believe Non-GAAP gross profit, Non-GAAP loss from operations and Non-GAAP net loss provide useful supplemental information to investors and others in understanding and evaluating our results of operations, as well as provide a useful measure for period-to-period comparisons of our business performance. We define free cash flow as net cash provided by operating activities less cash used for purchases of property and equipment. We believe that free cash flow is a useful indicator of liquidity that provides information to management and investors, even if negative, about the amount of cash used in our operations other than that used for investments in property and equipment. Other Business Metrics Annual Contract Value (ACV) – we define Annual Contract Value for an individual customer agreement as the total fixed fees under the agreement divided by the number of years in the agreement term. Our total ACV is the aggregate ACVs for all our customers as measured at a given point in time. Total fixed fees includes licensing, support and maintenance and other fixed fees under IP licensing or software licensing agreements but excludes variable revenue derived from licensing agreements with customers, particularly royalties. We define ACV plus royalties as ACV plus the trailing-twelve-months variable royalties and other revenue. Confirmed Design Starts – we define Confirmed Design Starts as when customers confirm their commencement of new semiconductor designs using our interconnect IP and notify us. Confirmed Design Starts is a metric management uses to assess the activity level of our customers in terms of the number of new semiconductor designs that are started using our interconnect IP in a given period. We believe that the number of Confirmed Design Starts is an important indicator of the growth of our business and future royalty revenue trends. Remaining Performance Obligations (RPO) – we define Remaining Performance Obligations as the amount of contracted future revenue that has not yet been recognized, including deferred revenue, billed and unbilled cancelable and non-cancelable contracted amounts. Arteris, Inc. Reconciliation of GAAP Measures to Non-GAAP Measures (In thousands, except share and per share data) (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Gross profit $ 15,642 $ 13,252 $ 45,408 $ 37,848 Add: Stock-based compensation expense included in cost of revenue 228 221 665 596 Amortization of acquired intangible assets (1) 50 50 150 150 Non-GAAP gross profit $ 15,920 $ 13,523 $ 46,223 $ 38,594 Gross margin 90 % 90 % 90 % 90 % Non-GAAP gross margin 91 % 92 % 92 % 91 % Research and development $ 12,648 $ 11,923 $ 36,681 $ 33,475 Stock-based compensation expense (2,095 ) (2,154 ) (5,994 ) (5,550 ) Amortization of acquired intangible assets (1) (110 ) (110 ) (330 ) (280 ) Non-GAAP research and development $ 10,443 $ 9,659 $ 30,357 $ 27,645 Sales and marketing $ 6,850 $ 4,962 $ 19,714 $ 15,431 Stock-based compensation expense (1,335 ) (850 ) (3,352 ) (2,230 ) Amortization of acquired intangible assets (1) (57 ) (57 ) (171 ) (171 ) Non-GAAP sales and marketing $ 5,458 $ 4,055 $ 16,191 $ 13,030 General and administrative $ 4,858 $ 4,286 $ 13,683 $ 13,436 Stock-based compensation expense (1,298 ) (1,165 ) (3,754 ) (3,431 ) Non-GAAP general and administrative $ 3,560 $ 3,121 $ 9,929 $ 10,005 Total operating expenses $ 24,356 $ 21,171 $ 70,078 $ 62,342 Stock-based compensation expense (4,728 ) (4,169 ) (13,100 ) (11,211 ) Amortization of acquired intangible assets (1) (167 ) (167 ) (501 ) (451 ) Total Non-GAAP operating expenses $ 19,461 $ 16,835 $ 56,477 $ 50,680 Loss from operations $ (8,714 ) $ (7,919 ) $ (24,670 ) $ (24,494 ) Stock-based compensation expense 4,956 4,390 13,765 11,807 Amortization of acquired intangible assets (1) 217 217 651 601 Non-GAAP loss from operations $ (3,541 ) $ (3,312 ) $ (10,254 ) $ (12,086 ) Net loss $ (8,991 ) $ (7,687 ) $ (26,242 ) $ (25,434 ) Stock-based compensation expense 4,956 4,390 13,765 11,807 Amortization of acquired intangible assets (1) 217 217 651 601 Non-GAAP net loss (2) $ (3,818 ) $ (3,080 ) $ (11,826 ) $ (13,026 ) Net loss per share attributable to common stockholders, basic and diluted $ (0.21 ) $ (0.20 ) $ (0.63 ) $ (0.66 ) Per share impacts of adjustments to net loss (3) $ 0.12 $ 0.12 $ 0.35 $ 0.32 Non-GAAP net loss per share attributable to common stockholders, basic and diluted $ (0.09 ) $ (0.08 ) $ (0.28 ) $ (0.34 ) Weighted-average shares used in computing per share amounts, basic and diluted 42,743,518 39,295,743 41,812,256 38,496,838 (1) Represents the amortization expenses of our intangible assets attributable to our acquisitions. (2) Our GAAP tax provision is primarily related to foreign withholding taxes and income tax in profitable foreign jurisdictions. We maintain a full valuation allowance against our deferred tax assets in the US. Accordingly, there is no significant tax impact associated with these Non-GAAP adjustments. (3) Reflects the aggregate adjustments made to reconcile Non-GAAP net loss to our net loss as noted in the above table, divided by the GAAP diluted weighted average number of shares of the relevant period. Free Cash Flow Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net cash provided by operating activities $ 3,187 $ 1,124 $ 3,563 $ 1,911 Less: Purchase of property and equipment (716 ) (31 ) (1,254 ) (274 ) Free cash flow $ 2,471 $ 1,093 $ 2,309 $ 1,637 Net cash (used in) provided by investing activities $ (1,631 ) $ (4,647 ) $ (1,047 ) $ 2,898 Net cash (used in) provided by financing activities $ (180 ) $ (775 ) $ 1,275 $ (676 ) View Comments Terms and Privacy Policy Privacy Dashboard More Info
  Content Reference URL	None

• Publisher

  Publisher Name	Financial Planning (#6135)
  Publisher URL	https://finance.yahoo.com
  Description	None
  Trust Flow Score	83
  Citation Flow Score	57

• Data Source

  Data Source Name	Yahoo Finance News (#2)
  Data Source Type	news
  Data Source URL	https://finance.yahoo.com/
  Description	Yahoo! Finance is a media property that is part of the Yahoo! network. It provides financial news, data and commentary including stock quotes, press releases, financial reports, and original content. It also offers some online tools for personal finance management.
  Weight	10